Literature DB >> 15304616

IV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study.

J M Heckmann, P Legg, D Sklar, J Fine, A Bryer, B Kies.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15304616     DOI： 10.1212/wnl.63.3.597

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

1.  Treatment of huntington disease.

Authors:  Aleksandar Videnovic
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

Review 2.  An Update on the Treatment of Chorea.

Authors:  Erin Feinstein; Ruth Walker
Journal:  Curr Treat Options Neurol       Date:  2018-09-25       Impact factor: 3.598

Review 3.  Symptomatic treatment of Huntington disease.

Authors:  Octavian R Adam; Joseph Jankovic
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

4.  An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington's Disease.

Authors:  Jean-Marc Burgunder; Mark Guttman; Susan Perlman; Nathan Goodman; Daniel P van Kammen; Lavonne Goodman
Journal:  PLoS Curr       Date:  2011-08-30

Review 5.  Pharmacological treatment of chorea in Huntington's disease-good clinical practice versus evidence-based guideline.

Authors:  Ralf Reilmann
Journal:  Mov Disord       Date:  2013-05-14       Impact factor: 10.338
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.